Flamingo Therapeutics to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
Flamingo Therapeutics., a biotechnology company pioneering RNA-targeting therapies in oncology, today announced that Mike Garrett, Chief Executive Officer and Rob MacLeod, ...